The epigenetic therapy of cancers is emerging as an effective and valuable approach to both chemotherapy and the chemoprevention of cancer. The utilization of epigenetic targets that include histone methyltransferase (HMTase), Histone deacetylatase, and DNA methyltransferase, are emerging as key therapeutic targets. SET containing proteins such as the HMTase Setd1b has been found significantly amplified in cancerous cells. In order to shed some light on the histone methyl transferase family, we cloned the Setd1b gene from Mus musculus and build a collection of vectors for recombinant protein expression in E.coli that will pave the way for further structural biology studies. We prospect the role of the Setd1b pathway in cancer therapy and detail its unique value for designing novel anti-cancer epigenetic-drugs.

생쥐에 1 Gray(Gy)와 3 Gy의 방사선을 조사한 후 시간에 따라 골격근, 심장, 신장, 간 및 정소조직의 형태적 변화를 확인하였다. H-B(hematoxylin-eosin)염색 결과 apoptotic body는 다른 조직에 비해 간조직에서 쉽게 관찰되었고, 조사량에 비례하였으며 대부분의 조직에서 조사 후 1일에, 정소조직에서는 7일에 많이 관찰되었다. TUNEL (terminal deoxyribonucleotidyl transferase-medi